SBC Experts Panel


Stevenage Bioscience Catalyst has established a panel of commercial, financial and technical experts to advise it and its tenants on all aspects of business development.


  • Donald Coppen PhD MBA

    Donald Coppen PhD MBA

    Donald is an experienced business development & alliance management executive of 15 years experience across the medtech, biotech & pharma sectors specialising in: • Conducting market research & drafting business plans; • Leading in-/out-licensing & acquisition... read more

  • Professor Bill Dawson

    Professor Bill Dawson

    Bionet Ltd Bill Dawson retired from Eli Lilly and Co in 1996 after 27 years service and established Bionet Ltd as a health care consultancy working at the interface between academia and industry. At Lilly, Bill was Research Director for 14 years and took 15 compounds into development, two of... read more

  • Tim Dempsey

    Tim Dempsey

    Founder, Epiphany Capital Tim can help companies with spin-out funding strategy syndicate building deal negotiation Tim has been involved with funding spin-outs and early stage healthcare companies since leaving university, establishing boutique corporate finance house Epiphany... read more

  • Barbara Domayne-Hayman

    Barbara Domayne-Hayman

    Dr Barbara Domayne-Hayman was Entrepreneur-in-Residence at SBC from Dec 2012 – Jan 2015, mentoring manyof the tenant companies and working with the SBC management team on a varietyof initiatives. These included SBC’s first Open Innovation Challenge inNeurodegenerative Disease, in... read more

  • Frank H. (Hal) Ebetino

    Frank H. (Hal) Ebetino

    PhD Industry Consultant Dr. Ebetino is a consultant for several start-up biotech organisations, and has continuing research efforts with several academic collaborators. He has recently been leading the Drug Discovery Department and the Medicinal Chemistry research laboratories which he... read more

  • Harry Finch

    Harry Finch

    PhD SVP Therapeutics, Pulmagen & NED Harry has many years' experience in drug discovery, development and medicinal chemistry in the pharmaceutical and biotechnology industry, and is SVP, Therapeutics, of Pulmagen Therapeutics. He has a PhD in organic chemistry, following which he worked at... read more

  • Paul Gerskowitch

    Paul Gerskowitch

    Strategic Transaction Advisor, Life Sciences & Healthcare Dr V Paul Gerskowitch was appointed to SBC’s Expert Panel at its inception. In this role he participated in various seminars and advised on funding strategies. He supports early stage companies under the SBC/BIS mentoring... read more

  • Martin Gunthorpe

    Martin Gunthorpe

    Martin is the Managing Director of Alterion Consulting Ltd, which he founded in 2010 to provide advice on scientific, business, fundraising and/o rlicensing strategy to start-up, biotech, pharma and venture capital companies. Martin has more than 20 years of research, drug discovery, and... read more

  • Max Herrmann

    Max Herrmann

    Consultant & CFO Max is an experienced Chief Financial Officer with more than 20 years experience in scientific and financial aspects of the pharmaceutical industry including roles in both industry and investment banking. He was until recently CFO of the AIM-listed RNAi company Silence... read more

  • Ray Hill

    Ray Hill

    B.Pharm Ph.D DSc (Hon) FMedSci Visiting Professor of Pharmacology/Honorary Business Development Advisor, Imperial College, London Dr Hill has worked extensively across the pharmaceutical industry and academia in pharmacology and neuroscience. Before his retirement from Merck at the end... read more

  • Paul Kemp

    Paul Kemp

    PhD Chief Executive and Chief Scientific Officer, Intercytex Paul Kemp has been involved in commercial regenerative medicine for over 20 years, and has a successful track record many aspects of private and public biotech business. This includes founding biotech companies, raising funding in... read more

  • Professor Chris Mason

    Professor Chris Mason

    MBBS PhD FSB FRCSI FRCS Chair in Regenerative Medicine Bioprocessing, UCL Professor Chris Mason is internationally recognised to be at the forefront of the emerging fields of cell therapy and regenerative medicine translation and commercialisation. Chris holds a Clinical Sciences degree from... read more

  • Sharon O'Kane

    Sharon O'Kane

    PhD Non-Executive Director and Business Advisor Sharon is a founder and until February 2010 was the Chief Scientific Officer and a Director at Renovo Group plc, which focused on the discovery and development of drugs to reduce scarring. She has a portfolio of non-executive director and... read more

  • James Otter    

    James Otter    

    James has spent the last four years focussed on a range of applications in health IT. He was CEO of Axon and OBS Medical, as well as leading the set-up of Oxehealth, which has given him exposure to telehealth, intelligent alarms, patient monitoring and medical records. As chair of Hygea VCT,... read more

  • Emma Palmer Foster

    Emma Palmer Foster

    Healthcare consultant EJ Palmer Consulting Emma Palmer Foster has over 20 years of experience in the European pharmaceutical and biotechnology sector, via roles in investment banking, financial communications and investor relations, journalism and technology transfer. This includes eight... read more

  • Dr Nick Pay

    Dr Nick Pay

    Founder, Nuage Vision Ltd Nick helps start-up companies and larger concerns specifically in the areas of Strategy planning Business model derivations Market Analyses Interim Management and human asset planning Investor ready business plan writing Presentation material for investor... read more

  • Chris Reilly

    Chris Reilly

    PhD Life Sciences Consultant Chris is an expert on the discovery and early clinical development of small molecule therapeutics across all disease areas. He is a regular visitor to SBC and has reviewed multiple opportunities for SBC and its tenants. He is also on the Discovery Assist... read more

  • Phillip Smith, PhD

    Phillip Smith, PhD

    Phillip has extensive experience of research in the NHS, with Universities and in the private Sector. His role over the last 16 years in the NHS has been to enable the conduct of high quality research relevant to patients. Phillip can help SBC Companies with: Identifying contacts in the... read more

  • Claire Thompson

    Claire Thompson

    Claire is new to the SBC experts panel and is currently working with MRC Technology on their strategy plans. She is very much looking forward to getting involved in the SBC plans for convergence, assisting tenants with product development, positioning and strategy, and running regular PR clinics. ... read more

  • Povl Verder

    Povl Verder

    Povl is Founder and CEO of Sime Diagnostics, an early stage medtech company developing digital in vitro diagnostics applications utilising big data analytics, software algorithms and machine learning. Previously he was Co-Founder of the Aston Group, where he advised big pharma and... read more

Funding Partners: